Ruthless Spine earned FDA 510(k) clearance for the NavJam Jamshidi device, according to a Sept. 18 news release.
NavJam works with Ruthless Spine’s de novo-cleared RJB intraoperative angle measurement instrument. Together they can minimize radiation, increase precision and simplify workflows.
The platform doesn’t require capital investment or specialized staff and has been adopted globally in Turkey, Ukraine and Africa.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
